{"protocolSection": {"identificationModule": {"nctId": "NCT03676114", "orgStudyIdInfo": {"id": "XuzhouMedSch3"}, "organization": {"fullName": "Xuzhou Medical University", "class": "OTHER"}, "briefTitle": "Effect of Perioperative Low Dose Ketamine on Postoperative Recovery in Patients Undergoing Breast Cancer Surgery", "officialTitle": "Effect of Perioperative Low Dose Ketamine on Postoperative Recovery in Patients Undergoing Breast Cancer Surgery"}, "statusModule": {"statusVerifiedDate": "2018-09", "overallStatus": "UNKNOWN", "lastKnownStatus": "RECRUITING", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2018-09-20", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2019-10", "type": "ESTIMATED"}, "completionDateStruct": {"date": "2020-02", "type": "ESTIMATED"}, "studyFirstSubmitDate": "2018-09-05", "studyFirstSubmitQcDate": "2018-09-15", "studyFirstPostDateStruct": {"date": "2018-09-18", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2018-09-19", "lastUpdatePostDateStruct": {"date": "2018-09-21", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR_INVESTIGATOR", "investigatorFullName": "Han Yuan", "investigatorTitle": "Doctor-in-charge of Anesthetist", "investigatorAffiliation": "Xuzhou Medical University"}, "leadSponsor": {"name": "Han Yuan", "class": "OTHER"}}, "oversightModule": {"isFdaRegulatedDrug": false, "isFdaRegulatedDevice": false}, "descriptionModule": {"briefSummary": "Breast cancer patients often have perioperative emotional disorders such as anxiety and depression, which can lead to poor quality of recovery.This study aims to determine whether ketamine could improve the quality of recovery in breast cancer patients. Meanwhile, it will show if ketamine could improve anxiety, depression, postoperative pain and fatigue.This trial also will bring great concerns on patients' mental health perioperatively and explore the measures to improve their quality of life."}, "conditionsModule": {"conditions": ["Breast Cancer"], "keywords": ["Ketamine", "Breast Cancer Surgery", "Postoperative Recovery"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE4"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "QUADRUPLE", "whoMasked": ["PARTICIPANT", "CARE_PROVIDER", "INVESTIGATOR", "OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 100, "type": "ESTIMATED"}}, "armsInterventionsModule": {"armGroups": [{"label": "ketamine group", "type": "EXPERIMENTAL", "interventionNames": ["Drug: ketamine"]}, {"label": "normal saline group", "type": "PLACEBO_COMPARATOR", "interventionNames": ["Drug: Normal saline"]}], "interventions": [{"type": "DRUG", "name": "ketamine", "description": "0.5mg/kg intravenous ketamine injection before incision followed by 0.25mg/kg/hr intravenous ketamine infusion during the operation", "armGroupLabels": ["ketamine group"]}, {"type": "DRUG", "name": "Normal saline", "description": "Same volume of normal saline will be administrated", "armGroupLabels": ["normal saline group"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "QoR40 score", "description": "Quality of recovery will be evaluated by Quality of Recovery 40 (QoR40),which assesses five dimensions of recovery (physical comfort,emotional state, physical independence , physiological support and pain ). Each item is rated on a five-point Likert scale: none of the time, some of the time, usually, most of the time, and all the time. The total score on the QoR40 ranges from 40 (poorest quality of recovery) to 200 (best quality of recovery).", "timeFrame": "the first day after surgery"}], "secondaryOutcomes": [{"measure": "ICFS scores", "description": "Fatigue state will be evaluated by Identity Consequence Fatigue Scale (ICFS).ICFS is based on a score of 31-173, higher scores representing worse state of fatigue.", "timeFrame": "Postoperative 3 days, 7 days and 30 days"}, {"measure": "HADS scores", "description": "Perioperative emotion will be evaluated by the hospital anxiety and depression scale（HADS）.The HADS is a fourteen item scale. Seven of the items relate to anxiety and seven relate to depression. The anxiety and depression subscales each range from 0 to 21, with higher scores indicating higher anxiety/depression complains. Patients were defined as having anxiety or depression or both if the score was 8 or more in the corresponding subscale.", "timeFrame": "Postoperative 2 days and 3months"}, {"measure": "Chronic Pain", "description": "The incidence of chronic pain at 3 months after surgery", "timeFrame": "3 months after surgery"}, {"measure": "NRS pain scores", "description": "Evaluate the severity using numerical rating scale（NRS）, where zero mean no pain and 10 the worst imaginable pain.", "timeFrame": "at 4 hours, 24 hours, and 48 hours after surgery"}, {"measure": "Postoperative complications", "description": "hallucination, nightmare and delirium will be recorded", "timeFrame": "Postoperative 1 day, 2 days and 3 days"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n1. American Society of Anesthesiologists Grade I-II\n2. Patients undergoing elective breast cancer surgery under general anesthesia\n\nExclusion Criteria:\n\n1. Unstable hypertension, history of heart disease\n2. Hepatic or renal dysfunction\n3. Patients undergoing chemotherapy before surgery\n4. Have a history of chronic pain or chronic use of analgesic\n5. Have mental illness or can't cooperate with investigators\n6. Have a history of ketamine allergy", "healthyVolunteers": false, "sex": "FEMALE", "minimumAge": "20 Years", "maximumAge": "65 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"centralContacts": [{"name": "Junli Cao", "role": "CONTACT", "phone": "+86 15162160809", "email": "caojl0310@yahoo.com.cn"}, {"name": "Yuan Han", "role": "CONTACT", "phone": "+86 13852470693", "email": "hanyuan-trial@163.com"}], "locations": [{"facility": "Department of Anesthesia of the Affiliated Hospital of Xuzhou Medical University", "status": "RECRUITING", "city": "Xuzhou", "state": "Jiangsu", "country": "China", "contacts": [{"name": "Cao Junli", "role": "CONTACT", "phone": "+86 15162160809", "email": "caojl0310@yahoo.com.cn"}, {"name": "Han Yuan", "role": "CONTACT", "phone": "+86 13852470693", "email": "hanyuan_trial@163.com"}], "geoPoint": {"lat": 34.20442, "lon": 117.28386}}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2025-09-17"}, "conditionBrowseModule": {"meshes": [{"id": "D001943", "term": "Breast Neoplasms"}], "ancestors": [{"id": "D009371", "term": "Neoplasms by Site"}, {"id": "D009369", "term": "Neoplasms"}, {"id": "D001941", "term": "Breast Diseases"}, {"id": "D012871", "term": "Skin Diseases"}, {"id": "D017437", "term": "Skin and Connective Tissue Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "D007649", "term": "Ketamine"}, {"id": "D000077330", "term": "Saline Solution"}], "ancestors": [{"id": "D003510", "term": "Cyclohexanes"}, {"id": "D003516", "term": "Cycloparaffins"}, {"id": "D006840", "term": "Hydrocarbons, Alicyclic"}, {"id": "D006844", "term": "Hydrocarbons, Cyclic"}, {"id": "D006838", "term": "Hydrocarbons"}, {"id": "D009930", "term": "Organic Chemicals"}, {"id": "D000077324", "term": "Crystalloid Solutions"}, {"id": "D007552", "term": "Isotonic Solutions"}, {"id": "D012996", "term": "Solutions"}, {"id": "D004364", "term": "Pharmaceutical Preparations"}]}}, "hasResults": false}
